92 related articles for article (PubMed ID: 16820144)
1. The clinical implications of increased coexpression of CD40-CD40 ligand system and C-reactive protein in patients after percutaneous coronary intervention.
Yan JC; Ma GS; Zhu J; Feng Y; Luo D; Wu ZG; KingG XT; Zong RQ; Zhan LZ
Clin Chim Acta; 2006 Dec; 374(1-2):140-1. PubMed ID: 16820144
[No Abstract] [Full Text] [Related]
2. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
[TBL] [Abstract][Full Text] [Related]
3. Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention.
Yan JC; Ding S; Liang Y; Ma GS; Zhu J; Feng Y; Luo D
Acta Pharmacol Sin; 2007 Mar; 28(3):339-43. PubMed ID: 17302995
[TBL] [Abstract][Full Text] [Related]
4. Effects of tirofiban and statins on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable coronary artery disease.
Azar RR; Badaoui G; Sarkis A; Kassab R; Salamé E; Klaymé S; Naman R; Germanos M
Am J Cardiol; 2005 Jan; 95(2):236-40. PubMed ID: 15642557
[TBL] [Abstract][Full Text] [Related]
5. Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.
L'Allier PL; Tardif JC; Grégoire J; Joyal M; Lespérance J; Fortier A; Guertin MC
Can J Cardiol; 2005 May; 21(6):495-500. PubMed ID: 15917878
[TBL] [Abstract][Full Text] [Related]
6. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease.
Lee WL; Lee WJ; Chen YT; Liu TJ; Liang KW; Ting CT; Huey-Herng Sheu W
Metabolism; 2006 Aug; 55(8):1029-34. PubMed ID: 16839837
[TBL] [Abstract][Full Text] [Related]
7. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
8. Is C-reactive protein a prognostic marker after angioplasty?
Tousoulis D; Papageorgiou N; Stefanadis C
Heart; 2009 Jun; 95(12):957-9. PubMed ID: 19478108
[No Abstract] [Full Text] [Related]
9. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
[TBL] [Abstract][Full Text] [Related]
10. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S
Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547
[TBL] [Abstract][Full Text] [Related]
11. [Inflammatory response after coronary angioplasty - mechanisms and significance].
Koziński M; Kubica J
Kardiol Pol; 2006 Jul; 64(7):771-4; author reply 775. PubMed ID: 16886140
[No Abstract] [Full Text] [Related]
12. Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
Rudolph T; Schaps KP; Steven D; Koester R; Rudolph V; Berger J; Terres W; Meinertz T; Kaehler J
Int J Cardiol; 2009 Mar; 132(3):392-7. PubMed ID: 18378332
[TBL] [Abstract][Full Text] [Related]
13. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and inflammation due to peripheral polymorphonuclear leukocytes after coronary angiography vs percutaneous coronary intervention.
Farah R; Shurtz-Swirski R; Bolotin Y; Brezins M
Minerva Cardioangiol; 2008 Apr; 56(2):189-95. PubMed ID: 18319697
[TBL] [Abstract][Full Text] [Related]
15. Predictors of target lesion revascularization in patients undergoing lower extremity percutaneous interventions.
Shammas NW; Shammas G; Bryan D; Rauba J; Dippel E; Jerin M
J Invasive Cardiol; 2009 Jun; 21(6):266-9. PubMed ID: 19494402
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of CD40-CD40 ligand system and serum cholesterol levels in patients with hypercholesterolemia.
Yan JC; Wu ZG; Li L; Zhong RQ; Kong XT
Chin Med J (Engl); 2004 Jul; 117(7):1101-3. PubMed ID: 15265391
[No Abstract] [Full Text] [Related]
17. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and restenosis: is there a link?
Bhatt DL
Am Heart J; 2004 Jun; 147(6):945-7. PubMed ID: 15199337
[No Abstract] [Full Text] [Related]
19. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting.
Yip HK; Wu CJ; Yang CH; Chang HW; Fang CY; Hung WC; Hang CL
Circ J; 2005 Aug; 69(8):890-5. PubMed ID: 16041155
[TBL] [Abstract][Full Text] [Related]
20. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation.
Hammwöhner M; Ittenson A; Dierkes J; Bukowska A; Klein HU; Lendeckel U; Goette A
Exp Biol Med (Maywood); 2007 Apr; 232(4):581-9. PubMed ID: 17392495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
